New vaccines for Mammalian allergy using molecular approaches (Q26998820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Gabrielle Pauli

series ordinal

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

2014

1 reference

published in

Frontiers in Immunology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

81

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json

Safety of engineered allergen-specific immunotherapy vaccines

11 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

New routes for allergen immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

The advent of recombinant allergens and allergen cloning

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

From allergen genes to allergy vaccines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Rational design of hypoallergens applied to the major cat allergen Fel d 1.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

T- and B-cell recognition of hepatitis B viral antigens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

The safety and efficacy of ALLERVAX CAT in cat allergic patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3954059

Childhood-to-adolescence evolution of IgE antibodies to pollens and plant foods in the BAMSE cohort.

31 May 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

A chimeric human-cat fusion protein blocks cat-induced allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Intralymphatic injections as a new administration route for allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Immunotherapy with cat- and dog-dander extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Covalent Coupling of Vitamin D3 to the Major Cat Allergen Fel d 1 Improves the Effects of Allergen-Specific Immunotherapy in a Mouse Model for Cat Allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00081

Skin prick test extracts for dog allergy diagnosis show considerable variations regarding the content of major and minor dog allergens

21 January 2018

1 reference

12 December 2020

Treatment of cat allergy with T-cell reactive peptides

1 reference

12 December 2020

Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response

1 reference

12 December 2020

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy

1 reference

12 December 2020

Immunotherapy with peptides

1 reference

12 December 2020

Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy

1 reference

12 December 2020

Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity

1 reference

12 December 2020

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

1 reference

12 December 2020

Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma

1 reference

12 December 2020

T cell epitope-containing peptides of the major dog allergen Can f 1 as candidates for allergen immunotherapy

1 reference

12 December 2020

In search of a vaccine for mouse allergy: significant reduction of Mus m 1 allergenicity by structure-guided single-point mutations

1 reference

12 December 2020

A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen

1 reference

12 December 2020

Identifiers

DOI

10.3389/FIMMU.2014.00081

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24672521%20AND%20SRC:MED&resulttype=core&format=json